Latest Breaking News On - Compass rose oncology funds - Page 1 : comparemela.com

FACIT announced $1.5 billion in follow-on investment attracted to its portfolio of cancer biotechnology start-ups in Ontario, a significant milestone for life science commercialization in Canada. FACIT partners with start-ups to commercialize their.

Vic fedeliLaszlo radvanyiDavid oneillJill dunlopFusion pharmaceuticalsOntario institute for cancer researchLife sciences strategyEconomic developmentDavido neillOntario instituteCancer researchProspects oncologyCompass rose oncology fundsOntario firstScientific directorJob creation